Correlation Between Cytek Biosciences and Neuropace
Can any of the company-specific risk be diversified away by investing in both Cytek Biosciences and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytek Biosciences and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cytek Biosciences and Neuropace, you can compare the effects of market volatilities on Cytek Biosciences and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytek Biosciences with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytek Biosciences and Neuropace.
Diversification Opportunities for Cytek Biosciences and Neuropace
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cytek and Neuropace is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Cytek Biosciences and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Cytek Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytek Biosciences are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Cytek Biosciences i.e., Cytek Biosciences and Neuropace go up and down completely randomly.
Pair Corralation between Cytek Biosciences and Neuropace
Given the investment horizon of 90 days Cytek Biosciences is expected to generate 16.02 times less return on investment than Neuropace. But when comparing it to its historical volatility, Cytek Biosciences is 1.35 times less risky than Neuropace. It trades about 0.01 of its potential returns per unit of risk. Neuropace is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 415.00 in Neuropace on August 31, 2024 and sell it today you would earn a total of 645.00 from holding Neuropace or generate 155.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cytek Biosciences vs. Neuropace
Performance |
| Timeline |
| Cytek Biosciences |
| Neuropace |
Cytek Biosciences and Neuropace Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cytek Biosciences and Neuropace
The main advantage of trading using opposite Cytek Biosciences and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytek Biosciences position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.| Cytek Biosciences vs. Orthopediatrics Corp | Cytek Biosciences vs. Electromed | Cytek Biosciences vs. Pulmonx Corp | Cytek Biosciences vs. Treace Medical Concepts |
| Neuropace vs. Abbott Laboratories | Neuropace vs. Medtronic PLC | Neuropace vs. Edwards Lifesciences Corp | Neuropace vs. ZimVie Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |